![Cam Gallagher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cam Gallagher
Président chez
OPUS GENETICS, INC.
Fortune : 9 M $ au 31/05/2026
Profil
Cam S.
Gallagher was the founder of Nerveda LLC, founded in 2007, serving as Managing Director.
Mr. Gallagher was the founder of DioGenix, Inc., founded in 2008, serving as Chairman.
Mr. Gallagher is the founder of Zentalis Pharmaceuticals, Inc., founded in 2014, serving as President, CFO, Treasurer & Director in 2024.
Current jobs include President, Chief Executive Officer & Director at Alessa Therapeutics, Inc. since 2024; Chairman at Opus Genetics, Inc. since 2019; Director at selectION, Inc. since 2018; Director at Immusoft Corp.
since 2022; Venture Partner at Mesa Verde Ventures LLC; and General Partner at Velosity Capital since 2021.
Former jobs include Marketing Director at CV Therapeutics, Inc. from 1992 to 2004; Director & Chief Business Officer at RetroSense Therapeutics LLC from 2014 to 2016; Independent Director at Sorrento Therapeutics, Inc. from 2012 to 2014; Director at Rexahn Pharmaceuticals, Inc. from 2019 to 2020; Director & Vice President-Corporate Development at Oncternal Oncology, Inc.; Director at OcuSub, Inc. from 2019 to 2020; Director at VelosBio, Inc. from 2017 to 2020; Director at Healios KK from 2022 to 2023; Director & Head-Corporate Development at Oncternal Therapeutics, Inc. from 2016 to 2019; Executive Director at Ray Therapeutics, Inc. from 2021 to 2023; Sales Management & Marketing Executive at Dura Pharmaceuticals, Inc. in 2004; Vice President-Marketing at Verus Pharmaceuticals, Inc. from 2004 to 2007; Senior Vice President-Business Development at Neurelis, Inc.; Chief Business Officer at jCyte, Inc. from 2019 to 2020; and Chief Business Officer at Kalyra Pharmaceuticals, Inc. from 2013 to 2024.
Education includes an undergraduate degree from The Ohio University in 1992 and an MBA from the University of San Diego in 1997.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OPUS GENETICS, INC. 2,58 % | 20/04/2026 | 2 098 797 ( 2,58 % ) | 9 M $ | 31/05/2026 |
Postes actifs de Cam Gallagher
| Sociétés | Poste | Début |
|---|---|---|
| OPUS GENETICS, INC. | Président | 01/12/2019 |
Alessa Therapeutics, Inc.
 Alessa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops localized treatments for solid organ diseases | Directeur Général | 16/12/2024 |
Mesa Verde Ventures LLC
 Mesa Verde Ventures LLC Investment ManagersFinance Mesa Verde Ventures invests in companies located in the United States primarily in California and the Southwest. The firm seeks investment opportunities in biotechnology and medical technology companies. It provides financing for early stage capital requirements. | Private Equity Investor | - |
Immusoft Corp.
 Immusoft Corp. Medical/Nursing ServicesHealth Services Provides disease curing services through immune cells | Directeur/Membre du Conseil | 01/01/2022 |
selectION, Inc.
 selectION, Inc. BiotechnologyHealth Technology Provides a technology platform to develop peptide blockers for ion channels | Directeur/Membre du Conseil | 01/06/2018 |
Anciens postes connus de Cam Gallagher
| Sociétés | Poste | Fin |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Fondateur | 13/11/2024 |
Kalyra Pharmaceuticals, Inc.
 Kalyra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures small molecule drugs | Corporate Officer/Principal | 01/01/2024 |
Ray Therapeutics, Inc.
 Ray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops optogenetic gene therapies for patients with blinding diseases | Directeur/Membre du Conseil | 01/05/2023 |
| HEALIOS K.K. | Directeur/Membre du Conseil | 01/03/2023 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Cam Gallagher
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
79
Relations au 1er degré
25
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 25 |
|---|---|
Dura Pharmaceuticals, Inc.
 Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets prescription pharmaceutical products | Health Technology |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Health Technology |
Verus Pharmaceuticals, Inc.
 Verus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pediatric-oriented pharmaceutical products | Health Technology |
Mesa Verde Ventures LLC
Mesa Verde Ventures LLC Investment ManagersFinance Mesa Verde Ventures invests in companies located in the United States primarily in California and the Southwest. The firm seeks investment opportunities in biotechnology and medical technology companies. It provides financing for early stage capital requirements. | Finance |
Nerveda LLC
 Nerveda LLC BiotechnologyHealth Technology Develops pharmaceutical and diagnostic technologies and drugs for neurological disorders | Health Technology |
RetroSense Therapeutics LLC
 RetroSense Therapeutics LLC Medical SpecialtiesHealth Technology Operates as a biotechnology company that focuses on developing gene therapy | Health Technology |
Kalyra Pharmaceuticals, Inc.
Kalyra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures small molecule drugs | Health Technology |
Immusoft Corp.
Immusoft Corp. Medical/Nursing ServicesHealth Services Provides disease curing services through immune cells | Health Services |
The Ohio University
 The Ohio University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of San Diego
 University of San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rexahn Pharmaceuticals, Inc.
 Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
DioGenix, Inc.
 DioGenix, Inc. Medical SpecialtiesHealth Technology Develops and commercializes novel, non-invasive diagnostic, prognostic and treatment response monitoring tests | Health Technology |
Neurelis, Inc.
 Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes product candidates for the treatment of central nervous system disorders | Health Technology |
Sorrento Therapeutics, Inc.
 Sorrento Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical and commercial stage biopharmaceutical company that develops treatments for cancer, infectious disease and pain | Health Technology |
selectION, Inc.
selectION, Inc. BiotechnologyHealth Technology Provides a technology platform to develop peptide blockers for ion channels | Health Technology |
Healios KK
 Healios KK Pharmaceuticals: MajorHealth Technology Engages in the research, development and manufacture of cell therapy and regenerative medicine products | Health Technology |
Oncternal Oncology, Inc.
 Oncternal Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company and manufactures pharmaceutical products | Health Technology |
VelosBio, Inc.
 VelosBio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in conducting biotechnological research activities | Commercial Services |
OcuSub, Inc.
 OcuSub, Inc. BiotechnologyHealth Technology Develops biological products | Health Technology |
Alessa Therapeutics, Inc.
Alessa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops localized treatments for solid organ diseases | Health Technology |
jCyte, Inc.
 jCyte, Inc. Medical/Nursing ServicesHealth Services Provides retinal therapy services | Health Services |
Oncternal Therapeutics, Inc.
 Oncternal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that manufactures pharmaceutical products | Health Technology |
Zentalis Pharmaceuticals, Inc.
 Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
Ocuphire Pharma, Inc.
 Ocuphire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals for eye disorders | Health Technology |
Ray Therapeutics, Inc.
Ray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops optogenetic gene therapies for patients with blinding diseases | Commercial Services |
